Back

Viscosity-corrected pulmonary vascular resistance: a prognostic marker in left ventricular assist device candidates

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension associated with left heart disease Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Balint Karoly Lakatos

Semmelweis University, Budapest (Hungary)

5 More presentations in this session

Presentation thumbnail
Diagnosing post-capillary pulmonary hypertension in the era of mild pulmonary hypertension: what is the optimal threshold of resting pulmonary arterial wedge pressure?
Doctor S. Taya (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Phenotypic characterization of pulmonary hypertension associated with left heart disease in contemporary practice: insights from the Re‑PHIRE Trial
Professor S. Rosenkranz (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Right heart dimensions and pulmonary arterial wedge pressure in pulmonary arterial hypertension: exploring a controversial relationship
Assistant Professor S. Papa (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Deep phenotyping of the right ventricular–pulmonary circulation reveals biological overlap between pulmonary arterial hypertension and combined post-capillary pulmonary hypertension
Doctor J. Rodriguez Arias (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Clinical and morphological profiles in different hemodynamic types of pulmonary hypertension in patients with mitral valve disease and predictors of persistent pulmonary hypertension post-surgery
Doctor S. Barbarash (Las Vegas, US)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary hypertension associated with left heart disease

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between early post-implantation pulmonary vascular resistance and clinical outcomes after LVAD implantation
11 May 2026
thumbnail
Congress Presentation
Prognostic value of composite hemodynamic indices in congenital heart disease-associated pulmonary hypertension: insights from a national multicenter prospective registry study
28 August 2026
thumbnail
Congress Presentation
Acute vasoreactivity test response in postcapillary pulmonary hypertension with preserved ejection fraction. PVR level matters
13 May 2024
thumbnail
Congress Presentation
By using the new hemodynamic definition of pulmonary hypertension in patients with left heart disease the prognostic value of different phenotypes might be lost
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources